Compare · head to head
Kamada vs Lhyfe
Kamada ranks higher overall — 360 rank 82 vs 9.
Kamada leads on Value (50 vs 32), Quality (68 vs 22) and Safety (62 vs 33). Lhyfe leads on Growth (57 vs 51). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Israel | France |
| Sector | Health Care | Energy & Oil |
| Industry | Biotechnology | Oil, Gas & Consumable Fuels |
| Size | Small | Small |
| ISIN | IL0010941198 | FR0014009YQ1 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 82 | 9 |
| Value | 50 | 32 |
| Quality | 68 | 22 |
| Growth | 51 | 57 |
| Safety | 62 | 33 |
| Sentiment | 54 | 53 |
| Quality details | ||
| Profitability | 83 | 15 |
| Cash Truth | 52 | 30 |
Kamada vs NovoCureKamada vs PharmingKamada vs NewAmsterdam Pharma CompanyKamada vs InModeAdd a third stock →
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100